EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PCSK9 promotes T helper 1 and T helper 17 cell differentiation by activating the nuclear factor‐κB pathway in ankylosing spondylitis

Jianfei Cai, Yinghui Jiang, Fucai Chen, Shubin Wu, Hongjun Ren, Pingping Wang, Jiayong Wang, Wei Liu iD

Immunity, Inflammation and Disease · 2023-05 · 11 (5)

DOI: 10.1002/iid3.870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 26.05.2023. Verfasst von Jianfei Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Huadong Hospital Affiliated with Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: NF-kappa B, Proprotein Convertase 9, Spondylitis, Ankylosing, Th1 Cells. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our previous study reveals that proprotein convertase subtilisin/kexin type 9 (PCSK9) is positively related to inflammatory markers, T helper (Th)‐17 cells, and treatment response in ankylosing spondylitis (AS) patients. Subsequently, this study aimed to explore the effect of PCSK9 on Th cell differentiation and its potential molecular mechanism in AS.

Methods

Serum PCSK9 was determined by enzyme‐linked immunosorbent assay in 20 AS patients and 20 healthy controls (HCs). Then naïve CD4 + T cells were isolated from AS patients and infected with PCSK9 overexpression or knockdown adenovirus followed by polarization assay. Afterward, PMA (an NF‐κB activator) was administrated.

Results

PCSK9 was increased in AS patients compared to HCs ( p < .001), and it was positively related to Th1 cells ( p = .050) and Th17 cells ( p = .039) in AS patients. PCSK9 overexpression increased the CD4 + IFN‐γ + cells ( p < .05), CD4 + IL‐17A + cells ( p < .01), IFN‐γ ( p < .01), and IL‐17A ( p < .01), while it exhibited no effect on CD4 + IL‐4 + cells or IL‐4 (both p > .05); its knockdown displayed the opposite function on them. Moreover, PCSK9 overexpression upregulated the p‐NF‐κB p65/NF‐κB p65 ( p < .01), while it had no effect on p‐ERK/ERK or p‐JNK/JNK (both p > .05); its knockdown decreased p‐NF‐κB p65/NF‐κB p65 ( p < .01) and p‐JNK/JNK ( p < .05). Then, PMA upregulates p‐NF‐κB p65/NF‐κB p65 ( p < .001) and increased CD4 + IFN‐γ + cells, CD4 + IL‐17A + cells, IFN‐γ, and IL‐17A (all p < .01), also it alleviated the effect of PCSK9 knockdown on NF‐κB inhibition and Th cell differentiation (all p < .01).

Conclusion

PCSK9 enhances Th1 and Th17 cell differentiation in an NF‐κB‐dependent manner in AS, while further validation is necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BProprotein Convertase 9Spondylitis, AnkylosingTh1 CellsTh17 CellsHumansCell DifferentiationInterleukin-17Interleukin-4Signal Transduction

Stichwörter der Autor:innen

T helper 1 cellsT helper 17 cellsankylosing spondylitisnuclear factor-κB pathwayproprotein convertase subtilisin/kexin type 9

Substanzen

Interleukin-17Interleukin-4NF-kappa BPCSK9 protein, humanProprotein Convertase 9

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, Huadong Hospital Affiliated with Fudan University, Shanghai, China.
  • Department of Traditional Chinese Medicine and Pharmacy, China Pharmaceutical University, Nanjing, China.
  • Department of Rheumatology and Immunology, Shanghai Qiang-zhi Hospital, Shanghai, China.

ORCID-Profile: Wei Liu

Zitieren

APA

Cai, J., Jiang, Y., Chen, F., Wu, S., Ren, H., Wang, P., Wang, J., & Liu, W. (2023). PCSK9 promotes T helper 1 and T helper 17 cell differentiation by activating the nuclear factor‐κB pathway in ankylosing spondylitis. Immunity, Inflammation and Disease, 11(5). https://doi.org/10.1002/iid3.870

Vancouver

Cai J, Jiang Y, Chen F, Wu S, Ren H, Wang P, et al. PCSK9 promotes T helper 1 and T helper 17 cell differentiation by activating the nuclear factor‐κB pathway in ankylosing spondylitis. Immunity, Inflammation and Disease. 2023;11(5). doi:10.1002/iid3.870

BibTeX
@article{Cai2023,
  author = {Cai, Jianfei and Jiang, Yinghui and Chen, Fucai and Wu, Shubin and Ren, Hongjun and Wang, Pingping and Wang, Jiayong and Liu, Wei},
  title = {PCSK9 promotes T helper 1 and T helper 17 cell differentiation by activating the nuclear factor‐κB pathway in ankylosing spondylitis},
  journal = {Immunity, Inflammation and Disease},
  year = {2023},
  volume = {11},
  number = {5},
  doi = {10.1002/iid3.870}
}
Kostenlos starten →